| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |